Oncotelic Therapeutics (OTLC) Assets (2010 - 2026)
Oncotelic Therapeutics (OTLC) posted Assets of $394.75 million for Q2 2026, compared with $26.68 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics' Assets came in at $393.09 million.
- Annual Assets shows a five-year compound annual growth rate of 75.4% (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Assets was $26.68 million in FY2024 (-11.1%), $30.01 million in FY2023 (-16.9%), $36.12 million in FY2022 (+53.0%) and $23.61 million in FY2021 (-0.2%).
- The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2010.
- On a year-over-year basis, Assets increased in 1 of the last five quarters, with an average decline of 7.8%.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2022, with growth of 73.5%; the weakest was Q2 2023, with a decline of 25.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 394.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 394.75 Mn |
| Dec 31, 2025 | 393.09 Mn |
| Sep 30, 2025 | 28.16 Mn |
| Jun 30, 2025 | 26.68 Mn |
| Mar 31, 2025 | 26.67 Mn |
| Dec 31, 2024 | 26.68 Mn |
| Sep 30, 2024 | 26.78 Mn |
| Jun 30, 2024 | 29.94 Mn |
| Mar 31, 2024 | 29.97 Mn |
| Dec 31, 2023 | 30.01 Mn |
| Sep 30, 2023 | 30.10 Mn |
| Jun 30, 2023 | 30.01 Mn |
| Mar 31, 2023 | 36.05 Mn |
| Dec 31, 2022 | 36.12 Mn |
| Sep 30, 2022 | 40.24 Mn |
| Jun 30, 2022 | 40.39 Mn |
| Mar 31, 2022 | 23.13 Mn |
| Dec 31, 2021 | 23.61 Mn |
| Sep 30, 2021 | 23.19 Mn |
| Jun 30, 2021 | 23.71 Mn |
API Access
Oncotelic Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();